Harrow Health Inc.

09/27/2022 | Press release | Distributed by Public on 09/27/2022 11:56

Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia